Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects.
Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
An exploratory Phase-II trial with intradermal RN1001 (Avotermin) to investigate scar
prevention and reduction and acceleration of healing. The trial has an additional objective
to evaluate several different scar assessment techniques that can be used in future clinical
trials in the prevention and reduction of scarring.